in

Novo Nordisk spends big in France to expand obesity drug capacity

Some say the weight-loss drugs market could grow to $100 billion by 2030

Some say the weight-loss drugs market could grow to $100 billion by 2030.

Danish pharmaceutical giant Novo Nordisk on Thursday announced a major investment in a French production site to expand capacity including for a blockbuster anti-obesity drug.


Posted by Editor

Amandine Ohayon Named CEO of Stella McCartney

Amandine Ohayon Named CEO of Stella McCartney

Global smartphone sales rebound in October after declining for more than 2 years: Counterpoint

Global smartphone sales rebound in October after declining for more than 2 years: Counterpoint